Page last updated: 2024-08-25

clarithromycin and pd 98059

clarithromycin has been researched along with pd 98059 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kanoh, S; Kubo, K; Rubin, BK; Tanabe, T; Tsushima, K; Yamazaki, Y	1

Other Studies

1 other study(ies) available for clarithromycin and pd 98059

Article	Year
Clarithromycin inhibits interleukin-13-induced goblet cell hyperplasia in human airway cells. American journal of respiratory cell and molecular biology, 2011, Volume: 45, Issue:5 Topics: Bronchi; Cell Differentiation; Clarithromycin; Enzyme Inhibitors; ErbB Receptors; Flavonoids; Goblet Cells; Heterocyclic Compounds, 3-Ring; Humans; Hyperplasia; Interleukin-13; Isoxazoles; Janus Kinases; Leflunomide; MAP Kinase Signaling System; Mucin 5AC; Mucus; NF-kappa B; Protein Synthesis Inhibitors; Pyridines; Respiratory Mucosa; Signal Transduction; STAT6 Transcription Factor	2011

Article

Year

Clarithromycin inhibits interleukin-13-induced goblet cell hyperplasia in human airway cells.

American journal of respiratory cell and molecular biology, 2011, Volume: 45, Issue:5

Topics: Bronchi; Cell Differentiation; Clarithromycin; Enzyme Inhibitors; ErbB Receptors; Flavonoids; Goblet Cells; Heterocyclic Compounds, 3-Ring; Humans; Hyperplasia; Interleukin-13; Isoxazoles; Janus Kinases; Leflunomide; MAP Kinase Signaling System; Mucin 5AC; Mucus; NF-kappa B; Protein Synthesis Inhibitors; Pyridines; Respiratory Mucosa; Signal Transduction; STAT6 Transcription Factor

2011